A GENETIC ANALYSIS OF HIV-1 INTEGRATION
HIV-1 整合的遗传分析
基本信息
- 批准号:6079219
- 负责人:
- 金额:$ 36.51万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2000
- 资助国家:美国
- 起止时间:2000-09-01 至 2005-08-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (adapted from applicant's abstract): This application outlines
studies to further explore the process of HIV-1 integration and integrase
function. The Applicant has developed a synoptic set of 82 charged
cluster-to-alanine mutants of integrase covering 93% of the charged residues,
and inserted these into an infectious molecular clone of HIV-1. He proposes to
examine several aspects of integrase biology in 3 Specific Aims. Aim 1 will
utilize a panel of 5 conditional integrase mutants to recover intra- and
extragenic viral suppressor mutants that suppress the original mutant
phenotype. It is hoped that this will lead to identification of viral ligands
that make critical intermolecular contact with the integrase protein during
virus replication. An HIV shuttle vector system has been developed which allows
direct cloning of circular DNA forms into bacteria, and which will facilitate
recovery and characterization of these suppressor mutants. Specific Aim 2 will
characterize the limited gene expression seen from circular DNA forms derived
from certain replication-defective integrase mutants. Kinetics, copy number,
and protein expression in primary cells will be assessed using real-time PCR
and reporter assays. These studies may have relevance to gene therapy protocols
and vaccine development. Aim 3 will further analyze a newly identified potent
nuclear localization signal present in the carboxy terminus of integrase.
Mutations in this region will be used to assess the role of this NLS in
infection of non-dividing cells.
描述(改编自申请人摘要):本申请概述
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(1)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MARK AYER MUESING其他文献
MARK AYER MUESING的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MARK AYER MUESING', 18)}}的其他基金
Maturational Intermediates of Trimeric HIV-1 Envelope as Unique Immunogens
三聚体 HIV-1 包膜的成熟中间体作为独特的免疫原
- 批准号:
8790245 - 财政年份:2014
- 资助金额:
$ 36.51万 - 项目类别:
HOST INTERACTIONS OF GENE PRODUCTS FROM HIV-1
HIV-1 基因产物的宿主相互作用
- 批准号:
8361508 - 财政年份:2011
- 资助金额:
$ 36.51万 - 项目类别:
HOST INTERACTIONS OF GENE PRODUCTS FROM HIV-1
HIV-1 基因产物的宿主相互作用
- 批准号:
8169125 - 财政年份:2010
- 资助金额:
$ 36.51万 - 项目类别:
HOST INTERACTIONS OF GENE PRODUCTS FROM HIV-1
HIV-1 基因产物的宿主相互作用
- 批准号:
7954081 - 财政年份:2009
- 资助金额:
$ 36.51万 - 项目类别:
相似海外基金
The mechanism of oral carcinogenesis by FAT1 gene mutation
FAT1基因突变导致口腔癌的机制
- 批准号:
23K15977 - 财政年份:2023
- 资助金额:
$ 36.51万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Development of an efficient method combining quantum chemistry and machine learning to evolve PCR technology and gene mutation analysis
开发一种结合量子化学和机器学习的有效方法来发展 PCR 技术和基因突变分析
- 批准号:
22KJ2450 - 财政年份:2023
- 资助金额:
$ 36.51万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Development of preemptive medicine for asymptomatic MEN1 gene mutation carriers
无症状MEN1基因突变携带者的抢先治疗药物开发
- 批准号:
23H03151 - 财政年份:2023
- 资助金额:
$ 36.51万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Elucidation of molecular mechanisms of occurrence of anaplastic thyroid cancer using gene mutation analysis and comprehensive gene expression analysis
利用基因突变分析和综合基因表达分析阐明甲状腺未分化癌发生的分子机制
- 批准号:
23K08067 - 财政年份:2023
- 资助金额:
$ 36.51万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Elucidation of the molecular mechanism of maxillofacial hypoplasia caused by FAT1 gene mutation
FAT1基因突变引起颌面发育不全的分子机制阐明
- 批准号:
22K19629 - 财政年份:2022
- 资助金额:
$ 36.51万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Association between CD79B gene mutation and prognosis in vitreoretinal lymphoma
CD79B基因突变与玻璃体视网膜淋巴瘤预后的关系
- 批准号:
22K09763 - 财政年份:2022
- 资助金额:
$ 36.51万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Gene mutation/expression prediction from clinical images using artificial intelligence technology in pancreatic cancer
利用人工智能技术从临床图像预测胰腺癌基因突变/表达
- 批准号:
20K17570 - 财政年份:2020
- 资助金额:
$ 36.51万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of colorectal carcinogenesis mediated by PTPRK gene mutation
PTPRK基因突变介导的结直肠癌发生机制的阐明
- 批准号:
20K16311 - 财政年份:2020
- 资助金额:
$ 36.51万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of the molecular mechanism of development of anaplastic thyroid cancer using gene mutation analysis and comprehensive gene expression analysis
利用基因突变分析和综合基因表达分析阐明甲状腺未分化癌发生的分子机制
- 批准号:
20K08953 - 财政年份:2020
- 资助金额:
$ 36.51万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of next-generation precision medicine targeting the pathways on which driver gene mutation-positive lung cancer depends
针对驱动基因突变阳性肺癌所依赖的途径开发下一代精准医疗
- 批准号:
20H03771 - 财政年份:2020
- 资助金额:
$ 36.51万 - 项目类别:
Grant-in-Aid for Scientific Research (B)














{{item.name}}会员




